tiprankstipranks
Advertisement
Advertisement
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
PremiumCompany AnnouncementsXTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
3M ago
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal
Premium
Company Announcements
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal
3M ago
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation
Premium
Company Announcements
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation
3M ago
Upcoming Stock Splits This Week (March 23 to March 27) – Stay Invested
PremiumMarket NewsUpcoming Stock Splits This Week (March 23 to March 27) – Stay Invested
4M ago
XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026
Premium
Company Announcements
XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026
5M ago
XTL Biopharmaceuticals announces ADS ratio change
Premium
The Fly
XTL Biopharmaceuticals announces ADS ratio change
5M ago
XTL Biopharmaceuticals Shareholders Approve Capital Increase and NeuroNOS-Linked Private Placement
PremiumCompany AnnouncementsXTL Biopharmaceuticals Shareholders Approve Capital Increase and NeuroNOS-Linked Private Placement
5M ago
XTL Biopharmaceuticals Faces Liquidation of Web Data Subsidiary After Insolvency Ruling
Premium
Company Announcements
XTL Biopharmaceuticals Faces Liquidation of Web Data Subsidiary After Insolvency Ruling
5M ago
XTL Biopharmaceuticals Adjourns Extraordinary Shareholders Meeting for Lack of Quorum
Premium
Company Announcements
XTL Biopharmaceuticals Adjourns Extraordinary Shareholders Meeting for Lack of Quorum
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100